Effects of HRT on serum levels of IGF-I in postmenopausal women

Maturitas

Volumn 40, Issue 1, 2001, Pages 69-74

  Posaci, Cemal ^a   Altunyurt, Sabahattin ^a   Islekel, Huray ^a   Onvural, Ata ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Hormone Replacement Therapy; IGF I; Oral and transdermal

Indexed keywords

ALENDRONIC ACID; ESTRADIOL PLUS NORETHISTERONE ACETATE; HORMONE; SOMATOMEDIN C;

ADULT; ARTICLE; CALCULATION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; NORETHINDRONE; POSTMENOPAUSE;

EID: 0035980421     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(01)00230-4     Document Type: Article

References (23)

1. Sex steroid regulation of growth hormone secretion and action
2. Effects of sex and age on the 24-h profile of growth hormone secretion in man: Importance of endogenous estradiol concentrations
3. Insulin-like growth factors I and II in healthy women with and without established osteoporosis
4. Circulating insulin-like growth factor system changes in women with acute estrogen deficiency induced by GnRH agonist
5. Synthesis and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: Dependence on growth hormone status
6. Contrasting effects of oral and transdermal routes of Estrogen replacement therapy on 24-h growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women
7. Biological effects of estradiol-17 beta in postmenopausal women: Oral versus percutaneous administration
8. Association between insulin-like growth factor I and bone mineral density in older women and men: The Framingham Heart Study
9. Effect of replacement estrogen on insulin-like growth factor-I in postmenopausal women: The Rancho Bernardo Study
10. Effects of oral and transdermal oestrogen replacement therapy on plasma levels of insulin-like growth factors and IGF binding proteins 1 and 3: A cross-over study
11. Transdermal 17 beta-estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor-I in postmenopausal women
12. Biologic effects of transdermal estradiol
13. Comparison of the effects of oral and transdermal oestradiol administration on oestrogen metabolism, protein synthesis, gonodotropin release, bone turnover and climacteric symptoms in postmenopausal women
14. Differential effects of estrogen and growth hormone on uterine and hepatic insulin-like growth factor I gene expression in the ovariectomized hypophysectomized rat
15. Effects of hormone replacement therapy on growth hormone secretion patterns in correlation to somatometric parameters in healthy postmenopausal women
16. Effects of hormonal replacement therapy on plasma sex hormone-binding globulin, androgen and insulin-like growth factor-1 levels in postmenopausal women
17. Effects of treatment with megestrol acetate, aminoglutethimide, or formestane on insulin-like growth factor (IGF) I and II, IGF-binding proteins (IGFBPs), and IGFBP-3 protease status in patients with advanced breast cancer
18. The effect of endocrine therapy with medroxyprogesterone acetate, 4-hydroxyandrostenedione or tamoxifen on plasma concentrations of insulin-like growth factor (IGF)-I, IGF-II and IGFBP-1 in women with advanced breast cancer
19. Androgenic progestogens oppose the decrease of insulin-like growth factor I serum level induced by conjugated oestrogens in postmenopausal women: Preliminary report
20. Insulin-like growth factors I and II: Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations
21. Effects of human growth hormone in men over 60 years old
22. Effect of estrogen deficiency on IGF-I plasma levels: Relationship with bone mineral density in perimenopausal women
23. Effect of natural menopause on serum levels of IGF-I and IGF-binding proteins: Relationship with bone mineral density and lipid metabolism in perimenopausal women